Colbun (COLBUN)
Santiago Stock Exchange · Chile · prices in CLP · close of 27 Oct 2026
Key indicators
| Last close | CLP 149.50 |
|---|---|
| 52-week range | 123.55 – 156.51 |
| Return, 1 month / 3 months | +1.4% / +11.2% |
| Return, 1 year / 3 years | +7.4% / +41.6% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 21.9% |
| Worst drawdown (1 year) | -19.3% |
| Average daily value traded | 2,491.74M CLP |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Colbun is a Chilean electricity generator based in Santiago. The company produces power from hydroelectric, thermal and solar plants and supplies it to regulated distribution companies and large industrial customers across Chile. Its business centres on generating and trading electricity, and it also takes part in transmission and energy-related projects. Colbun serves households and businesses through the country's electricity system, drawing on a mix of generation sources to meet demand.
The shares are listed on the Santiago Stock Exchange in Chile under the code COLBUN, and the price on this page is in Chilean pesos (CLP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Colbun (COLBUN) trades on the Santiago Stock Exchange in Chile. It last closed at CLP 149.50 on 27 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 27 of 112 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.4% and over the last three months it rose 11.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Santiago Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 74 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.7% | ||
| From 52-week high | -2.9% | ||
| Momentum | 61 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.2% | ||
| 6-month return | 7.6% | ||
| 12-month return, skipping the last month | 5.9% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 21.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.3% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 2,491.74M CLP | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | +1.4% |
| 3 months | +11.2% |
| 6 months | +7.6% |
| 1 year | +7.4% |
| 3 years | +41.6% |
| 5 years | +229.2% |
Signals
| 50-day / 200-day average | 147.11 / 138.79 |
|---|---|
| Golden / death cross (60 days) | Golden, 39 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | CLP 0.8009 |
| 9 Dec 2025 | CLP 4.1247 |
| 5 May 2025 | CLP 1.4189 |
| 9 Dec 2024 | CLP 5.5331 |
| 6 May 2024 | CLP 1.4388 |
| 11 Dec 2023 | CLP 8.4023 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Santiago Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.